DermTech (DMTK) Misses Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts DMTK Hot Sheet
Join SI Premium – FREE
DermTech (NASDAQ: DMTK) reported Q1 EPS of ($1.02), $0.11 worse than the analyst estimate of ($0.91). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $3.5 million.
For earnings history and earnings-related data on DermTech (DMTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Madrigal Pharma (MDGL) Tops Q2 EPS by 76c
- Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
